Fentanyl makers shift to peptides as ACA enrollment drops post-subsidy expiration
1h ago· 3 min readenNews
Summary
This newsletter snippet covers two main stories: (1) Fentanyl manufacturers are reportedly pivoting to producing peptides, a shift in the illicit drug market; (2) Affordable Care Act (Obamacare) enrollment is dropping significantly in several states — including Ohio, Oklahoma, Arizona, South Carolina, and Minnesota — following the expiration of enhanced federal subsidies. The article notes these coverage losses are affecting both red and blue states.
Source
bskyFentanyl makers shift to peptides as ACA enrollment drops post-subsidy expirationaxios.comKey quotes
· 2 pulledOhio, Oklahoma, Arizona, South Carolina and Minnesota have sustained some of the deepest losses in Affordable Care Act coverage since beefed-up federal subsidies expired this year
The coverage losses are hitting deep-red states as well as blue ones
1 big thing: Fentanyl makers pivot to peptides
You might also wanna read
Obamacare rolls shrank dramatically in many states over the past year, new federal data shows
The Independent·16h ago
Obamacare rolls shrank dramatically in many states over the past year, new federal data shows
apnews.com·16h ago
Obamacare rolls shrank dramatically in many states over the past year, new federal data shows
greeleytribune.com·14h ago
Obamacare rolls shrank dramatically in many states over the past year, new federal data shows - Seymour Tribune
tribtown.com·16h ago
Obamacare rolls shrank dramatically in many states over the past year, new federal data shows
STAT·16h ago
Estonia Won the War on Fentanyl. What Came Next Was Even Worse.
NYT·3h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.